Month: February 2021

COLUMBUS, Ohio, Feb. 11, 2021 (GLOBE NEWSWIRE) — In conjunction with the L Brands (NYSE: LB) fourth quarter 2020 earnings release, which will cross the wire after market close on Wednesday, Feb. 24, you are invited to listen to a live webcast of the conference call on Thursday, Feb. 25 at 9:00 a.m. ET with L Brands executives.If you are unable to participate during the live webcast, the call will also be archived and made available on www.LB.com.ABOUT L BRANDS:L Brands, through Victoria’s Secret, PINK and Bath & Body Works, is an international company. The company operates 2,669 company-operated specialty stores in the United States, Canada and Greater China, and its brands are also sold in more than 700 franchised locations worldwide. The company’s products are also available online at www.BathandBodyworks.com, www.VictoriasSecret.com...

FARMINGDALE, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) — Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be participating in two upcoming investor conferences.BTIG Virtual MedTech, Digital Health, Life Science & Diagnostics Tools ConferenceDates: February 17th and 18thManagement will host a presentation on Wednesday, February 17th at 2:00 p.m. EST10thAnnual SVB Leerink Global Healthcare ConferenceDates: February 24th, 25th and 26thManagement will host a fireside chat on Friday, February 26th at 8:00 a.m. ESTFor more information about the conferences or to schedule a virtual one-on-one meeting...

MUNCIE, Ind., Feb. 11, 2021 (GLOBE NEWSWIRE) — First Merchants Corporation, a $14.1 billion financial holding company, has elected Susan Brooks and Mark Hardwick to the Board of Directors of First Merchants Corporation and First Merchants Bank. Brooks represented Indiana’s 5th Congressional District in the U.S. House of Representatives, and Hardwick is Chief Executive Officer of First Merchants Corporation and First Merchants Bank. Both Ms. Brooks and Mr. Hardwick will be on the ballot for continuing terms at the Corporation’s Annual Shareholder Meeting in May 2021.  “First Merchants’ Board of Directors is happy to welcome Mr. Hardwick and Ms. Brooks, both of whom are exemplary leaders, to our board,” said Board Chairman Charles E. Schalliol. “I believe First Merchants shareholders and clients will share our enthusiasm...

STEAMBOAT SPRINGS, Colo., Feb. 11, 2021 (GLOBE NEWSWIRE) — WESTERN SIERRA RESOURCE COPORATION (“WSRC” or the “Company”) (OTC: WSRC). Since the Company’s announcement of its acquisition of MPG on September 15, 2020, MPG’s founder and WSRC director, Ken Pearson, has advised WSRC on MPG’s plan to transform the HVAC (air-conditioning) retrofit program with its estimated 40-45% power reduction per ton of cooling. Acting on the advice of MPG’s senior scientist, John Scarbrough, the retrofit HVAC program will add an integrated solid oxide fuel cell with a patent pending high efficiency waste heat engine-generator. Collectively, the Energy Tree (consisting of the HVAC retrofit, combined with Solid Oxide Fuel Cell, and Waste Heat Exchange Engine Generator) expects to deliver an elevated thermal efficiency near 70%. The initial intended markets...

Orlando, Florida, Feb. 11, 2021 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands, announced the addition of Jill Golder to the company’s Board of Directors. Ms. Golder served as the Chief Financial Officer for Cracker Barrel Old Country Store (NYSE:CBRL) until her retirement on December 31, 2020. As Chief Financial Officer, Ms. Golder managed all areas of Corporate Finance, Accounting, Investor Relations, Internal Audit, Strategic Planning and Information Technology for the company. Ms. Golder currently serves as a Board Member for ABM Industries (NYSE: ABM), a Fortune 500 company and leading provider of facility solutions with offices throughout the United States and various international locations.Ms. Golder has 31...

MCLEAN, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey (PMMS), showing that the 30-year fixed-rate mortgage (FRM) averaged 2.73 percent.“It’s a tale of two economies. The services economy remains in the doldrums, but the production side of the economy remains strong,” said Sam Khater, Freddie Mac’s Chief Economist. “New COVID-19 cases are receding, which is encouraging and that has led to a rise in Treasury rates. But, the run-up in Treasury rates has not impacted mortgage rates yet, which have held firm.”Khater continued, “The residential real estate market remains solid given healthy purchase demand while implied real-time home price growth is high, due to the inventory shortage that is plaguing the housing market.”News Facts30-year fixed-rate mortgage...

WILMINGTON, Del., Feb. 11, 2021 (GLOBE NEWSWIRE) — According to a new WSFS Bank Study of Millennials and Gen Z consumers, 65% of respondents describe their overall financial situation as either “good” or “excellent,” and six in 10 (58%) are optimistic that they’ll achieve their financial goals one day. The nationwide study asked 2,005 people between the ages of 18-40 to describe their financial fears and goals, as well as how their experiences have been informed by previous generations.While respondents remain optimistic when it comes to their finances, 43% said they frequently have trouble paying everyday living expenses, with 19% saying it happens to them “constantly.” Despite this, 58% of respondents think their generation’s level of financial stability is actually better than that of previous generations.“While overspending...

加利福尼亚州旧金山, Feb. 11, 2021 (GLOBE NEWSWIRE) — 天演药业 （Adagene Inc.）（以下简称“天演药业”或“公司”）（纳斯达克股票代码：ADAG），一家平台驱动型的、致力于创新抗体技术癌症免疫疗法发现和开发的临床阶段生物制药企业，今天宣布完成8,457,100美国存托股票（“ADS”）的首次公开发行（“IPO”），其中包括行使承销商的超额配股权的1,103,100美国存托股票，每股美国存托股票为19美元。扣除承销折扣和佣金以及估计发行费用之前，此次IPO实收款项累计总额约为161百万美元。每份美国存托股票代表一又四分之一（1.25）股公司普通股。该ADS已于美国时间2021年2月 9 日在纳斯达克全球市场开始交易，股票代码为“ADAG”。Goldman Sachs (Asia) L.L.C.，Morgan Stanley & Co. LLC，Jefferies LLC担任本次发行的联席账簿管理人。China Renaissance Securities (Hong Kong) Limited担任本次发行的联席经理。借助计算生物学和人工智能，天演药业自主研发了万亿级动态精准全人源抗体库（DPL），深度布局肿瘤免疫及靶向治疗药物的开发，所产生的先导抗体不仅可针对不同的抗原表位，还具有物种交叉反应，可使用各种免疫完整动物模型进行临床前研究，从而实现从临床前到临床研究的高转化率。同时，这类先导抗体也具备优异的生物学功能和成药性，大幅提高抗体药物的发现效率，提升抗体药物的稳定性及下游生产工艺的开发。凭借其全球首创的三体平台技术（新表位抗体NEObody，安全抗体SAFEbody及强力抗体POWERbody），天演药业精心打造了独具特色的在研产品管线，当前已有4款产品进入临床试验阶段。高度差异化的两款临床产品ADG116（NEObody）和ADG126（SAFEbody）针对CTLA-4 的独特表位并具有全新的作用机制，包括通过柔性配体阻断实施的CTLA-4动态调节，以及调节性T细胞的高效清除。在临床I期剂量递增探索试验中，ADG116已完成第四剂量水平八例病人给药。另外，复合晶体结构显示ADG116靶向与已批准或者其他临床开发中的产品迥然不同的独特抗原表位。...

SAN FRANCISCO, Feb. 11, 2021 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene” or the “Company”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies, today announced the closing of its initial public offering (the “IPO”) of 8,457,100 American depositary shares (“ADSs”), at public offering price of US$19.00 per ADS. The number of ADSs issued at closing included the exercise in full of the underwriters’ option to purchase 1,103,100 additional ADSs from the Company. The aggregate gross proceeds from the IPO were approximately US$161 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. Each ADS represents...

The compound is currently in Phase IINow has orphan designation in both U.S. and EUMADRID, Spain and CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s first-in-class LSD1 inhibitor iadademstat for the treatment of patients with acute myeloid leukemia (AML). Iadademstat is an investigational, oral, small molecule covalent inhibitor of the epigenetic enzyme LSD1, a chromatin remodeler that interacts with a variety of transcription factors involved in leukemia and other cancers.“Receiving Orphan Drug Designation for iadademstat...